PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 82 filers reported holding PMV PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -99.9% | 470 | -99.9% | 0.00% | -100.0% |
| Q4 2021 | $12,058,000 | -49.7% | 522,000 | -35.1% | 0.25% | -45.9% |
| Q3 2021 | $23,959,000 | -12.8% | 804,000 | 0.0% | 0.47% | -4.1% |
| Q2 2021 | $27,465,000 | +97.1% | 804,000 | +89.8% | 0.49% | +66.6% |
| Q1 2021 | $13,935,000 | +21.0% | 423,680 | +126.3% | 0.29% | +28.5% |
| Q4 2020 | $11,514,000 | +548.7% | 187,192 | +274.4% | 0.23% | +430.2% |
| Q3 2020 | $1,775,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |